DK162511C - Baerestof for farmaceutiske praeparater og langtidsvirkende farmaceutiske praeparater indeholdende et saadant baerestof - Google Patents

Baerestof for farmaceutiske praeparater og langtidsvirkende farmaceutiske praeparater indeholdende et saadant baerestof

Info

Publication number
DK162511C
DK162511C DK569784A DK569784A DK162511C DK 162511 C DK162511 C DK 162511C DK 569784 A DK569784 A DK 569784A DK 569784 A DK569784 A DK 569784A DK 162511 C DK162511 C DK 162511C
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
carrier
carbon
long
effective
Prior art date
Application number
DK569784A
Other languages
Danish (da)
English (en)
Other versions
DK162511B (da
DK569784D0 (da
DK569784A (da
Inventor
Hans Lowey
Original Assignee
Hans Lowey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hans Lowey filed Critical Hans Lowey
Publication of DK569784D0 publication Critical patent/DK569784D0/da
Publication of DK569784A publication Critical patent/DK569784A/da
Publication of DK162511B publication Critical patent/DK162511B/da
Application granted granted Critical
Publication of DK162511C publication Critical patent/DK162511C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK569784A 1983-12-01 1984-11-30 Baerestof for farmaceutiske praeparater og langtidsvirkende farmaceutiske praeparater indeholdende et saadant baerestof DK162511C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/556,844 US4680323A (en) 1983-12-01 1983-12-01 Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
US55684483 1983-12-01

Publications (4)

Publication Number Publication Date
DK569784D0 DK569784D0 (da) 1984-11-30
DK569784A DK569784A (da) 1985-06-02
DK162511B DK162511B (da) 1991-11-11
DK162511C true DK162511C (da) 1992-03-30

Family

ID=24223083

Family Applications (1)

Application Number Title Priority Date Filing Date
DK569784A DK162511C (da) 1983-12-01 1984-11-30 Baerestof for farmaceutiske praeparater og langtidsvirkende farmaceutiske praeparater indeholdende et saadant baerestof

Country Status (26)

Country Link
US (1) US4680323A (de)
JP (1) JPS60185728A (de)
KR (1) KR930000046B1 (de)
AT (1) AT394948B (de)
AU (1) AU572571B2 (de)
BE (1) BE901186A (de)
CA (1) CA1229551A (de)
CH (1) CH664970A5 (de)
DE (1) DE3443587C2 (de)
DK (1) DK162511C (de)
EG (1) EG17134A (de)
FI (1) FI82601C (de)
FR (1) FR2555901B1 (de)
GB (1) GB2152940B (de)
HU (1) HU193717B (de)
IE (1) IE58112B1 (de)
IL (1) IL73594A (de)
IT (1) IT1177152B (de)
LU (1) LU85660A1 (de)
MX (1) MX161165A (de)
NL (1) NL193164C (de)
NO (1) NO167002C (de)
NZ (1) NZ210310A (de)
PT (1) PT79427B (de)
SE (1) SE461071B (de)
ZA (1) ZA849373B (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
EP0153105B1 (de) * 1984-02-10 1992-09-09 Benzon Pharma A/S Dosierungsform eine Vielzahl mit einer Diffusionshülle überzogener Einheiten enthaltend
JPS6185315A (ja) * 1984-10-04 1986-04-30 Teikoku Seiyaku Kk シ−ト状製剤
JPS61286330A (ja) * 1985-06-11 1986-12-16 Teijin Ltd 経口徐放性製剤
EP0205336B1 (de) * 1985-06-11 1991-09-11 Teijin Limited Oral-Arzneizubereitung mit Retardwirkung
GB8518927D0 (en) * 1985-07-26 1985-09-04 Vincent Processes Ltd Tablets
US4704285A (en) * 1985-11-18 1987-11-03 The Dow Chemical Company Sustained release compositions comprising hydroxypropyl cellulose ethers
JPS62120315A (ja) * 1985-11-20 1987-06-01 Shin Etsu Chem Co Ltd 経口投与型徐放性錠剤の製造方法
IL85538A (en) * 1987-02-27 1991-09-16 Lilly Co Eli Sustained release matrix tablet formulations containing hydrophilic and enteric polymers
US4783331A (en) * 1987-06-29 1988-11-08 Miles Inc. Method for solubilization of aspartame in effervescent aqueous systems; and composition
WO1989010745A1 (en) * 1988-05-02 1989-11-16 Pomerantz, Edwin Compositions and in situ methods for forming films on body tissue
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5268181A (en) * 1989-04-13 1993-12-07 Upsher-Smith Laboratories, Inc. Method of using niacin to control nocturnal cholesterol synthesis
US5126145A (en) * 1989-04-13 1992-06-30 Upsher Smith Laboratories Inc Controlled release tablet containing water soluble medicament
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
JP2845342B2 (ja) * 1990-04-28 1999-01-13 大正製薬株式会社 ビタミンｄ▲下３▼誘導体含有固形製剤組成物
ES2067957T3 (es) * 1990-08-07 1995-04-01 Pfizer Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion.
WO1992017166A1 (en) * 1991-04-08 1992-10-15 Nippon Shinyaku Co., Ltd. Capsule
US5204116A (en) * 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy
DE69224809T2 (de) * 1991-12-30 1998-07-09 Akzo Nobel Nv Thyroaktive Zusammensetzung mit kontrollierter Freigabe
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
DE4341156C2 (de) * 1993-12-02 1997-11-13 Wacker Chemie Gmbh Verwendung von in Wasser redispergierbaren Kunststoffdispersionspulvern als Arzneimittelträger
US5840756A (en) * 1995-07-21 1998-11-24 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition of L-DOPA ester
EP0906089B1 (de) * 1996-05-13 2003-08-27 Novartis Consumer Health S.A. Mundfreisetzungssystem
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US6479082B1 (en) 1996-12-23 2002-11-12 Wm. Wrigley, Jr. Co. Process of increasing flavor release from chewing gum using hydroxypropyl cellulose and product thereof
CA2216215A1 (en) 1997-04-05 1998-10-05 Isa Odidi Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
TR200001362T2 (tr) * 1997-11-12 2000-09-21 Boehringer Mannheim Pharm Corp.-Smithkline Beckman Yeni karvedilol oral dozaj formu
US6207682B1 (en) 1998-12-22 2001-03-27 Novo Nordisk A/S Modified release formulations containing (R)-1-(10,11-dihydro-5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1propyl)-3-piperidinecarboxylic acid
AU1649700A (en) * 1998-12-22 2000-07-12 Novo Nordisk A/S Novel formulation
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
WO2000059314A1 (en) 1999-04-01 2000-10-12 Wm. Wrigley Jr. Company Long flavor duration releasing structures for chewing gum
US6372252B1 (en) * 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
AU2141202A (en) 2000-12-05 2002-06-18 Alexander Macgregor Hydrostatic delivery system for controlled delivery of agent
US20030044462A1 (en) * 2001-08-20 2003-03-06 Kali Laboratories, Inc. Sustained release tablets containing bupropion hydrochloride
US20030167556A1 (en) * 2002-03-05 2003-09-11 Consumers Choice Systems, Inc. Methods and devices for transdermal delivery of anti-aging compounds for treatment and prevention of facial or neck skin aging
EP1556014A1 (de) * 2002-10-22 2005-07-27 Ranbaxy Laboratories, Ltd. Alfuzosin enthaltende zusammensetzungen mit verzlängerter freisetzung
US20080318837A1 (en) * 2003-12-26 2008-12-25 Nastech Pharmaceutical Company Inc. Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide
US20060074025A1 (en) * 2003-12-26 2006-04-06 Nastech Pharmaceutical Company Inc. Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
US20050143303A1 (en) * 2003-12-26 2005-06-30 Nastech Pharmaceutical Company Inc. Intranasal administration of glucose-regulating peptides
US20060210614A1 (en) * 2003-12-26 2006-09-21 Nastech Pharmaceutical Company Inc. Method of treatment of a metabolic disease using intranasal administration of exendin peptide
US20060057165A1 (en) * 2004-09-10 2006-03-16 Dimitrios Dimitrakoudis Clostridium botulinum toxin formulation and method for reducing weight
DK1812025T3 (da) 2004-11-02 2012-10-22 Chr Hansen As Stabiliserede bakteriofagformuleringer
CN101277699B (zh) * 2005-08-23 2011-01-12 日产化学工业株式会社 缓释制剂
WO2007067964A2 (en) * 2005-12-08 2007-06-14 Nastech Pharmaceutical Company Inc. Mucosal delivery of stabilized formulations of exendin
US20070185035A1 (en) * 2005-12-23 2007-08-09 Nastech Pharmaceutical Company Inc. Enhanced mucosal administration of neuroprotective peptides
AU2008210327B2 (en) * 2007-01-31 2011-06-16 Methylation Sciences International Srl Extended release pharmaceutical formulations of S-adenosylmethionine
US20090088404A1 (en) * 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
US20090197824A1 (en) * 2008-01-31 2009-08-06 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
WO2008102235A1 (en) * 2007-02-20 2008-08-28 Aurobindo Pharma Limited Controlled release formulations of alfuzosin
US20090042795A1 (en) * 2007-06-05 2009-02-12 Pasan Fernando Cardiac stem cell proliferation proteins, fragments thereof and methods of modulating stem cell proliferation and differentiation
KR100836960B1 (ko) * 2007-09-07 2008-06-10 주식회사 서울제약 새로운 나이아신 제어방출형 제제
US7928189B2 (en) * 2008-05-05 2011-04-19 Ottawa Health Research Institute PCSK9 polypeptide fragment
CN102098921A (zh) * 2008-05-19 2011-06-15 温顿制药有限公司 高载量、控释镁口服制剂及其制备和使用方法
US20110027342A1 (en) * 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
US11827904B2 (en) 2015-04-29 2023-11-28 Fred Hutchinson Cancer Center Modified stem cells and uses thereof
WO2017062997A1 (en) 2015-10-09 2017-04-13 Reckitt Benckiser Llc Pharmaceutical formulation
CN115429815B (zh) * 2021-06-02 2023-12-22 广州帝奇医药技术有限公司 一种长效饱腹组合物、制备方法及用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2887440A (en) * 1957-08-12 1959-05-19 Dow Chemical Co Enteric coating
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
US3138524A (en) * 1962-06-06 1964-06-23 Hoffmann La Roche Pharmaceutical suspensions
US3428728A (en) * 1965-10-21 1969-02-18 Hans Lowey Timed release sublingual medications
GB1171691A (en) * 1967-02-24 1969-11-26 Forest Laboratories Lond-Acting Oral Carrier
US3590117A (en) * 1969-03-24 1971-06-29 Richardson Merrell Inc Long-lasting troche containing guar gum
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
GB1279214A (en) * 1970-01-22 1972-06-28 Forest Laboratories Long-acting oral carrier
CA945899A (en) * 1971-09-16 1974-04-23 Hans Lowey Long-acting oral carrier
GB1430684A (en) * 1972-06-26 1976-03-31 Lowey H Prolonged release lozenges
US3876771A (en) * 1973-09-04 1975-04-08 Hallister Inc Skin protective gel containing polyvinyl methylether or monoisopropyl ester of polyvinyl methylether maleic acid
YU43437B (en) * 1976-05-05 1989-08-31 Lowey Hans Process for obtaining tablets containing an active component with long lasting effect
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS55118414A (en) * 1979-03-05 1980-09-11 Teijin Ltd Prolonged release drug and its preparation
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4357469A (en) * 1979-06-14 1982-11-02 Forest Laboratories, Inc. Carrier base material for prolonged release therapeutic compositions
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
JPS58192817A (ja) * 1982-05-06 1983-11-10 Nippon Soda Co Ltd 棒状製剤の製造方法
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose

Also Published As

Publication number Publication date
CH664970A5 (de) 1988-04-15
LU85660A1 (de) 1985-06-04
FI844656L (fi) 1985-06-02
AU3449984A (en) 1985-06-06
AU572571B2 (en) 1988-05-12
SE8406081L (sv) 1985-06-02
PT79427A (en) 1984-11-01
NL8403522A (nl) 1985-07-01
ZA849373B (en) 1985-07-31
FR2555901B1 (fr) 1988-06-10
HU193717B (en) 1987-11-30
DK162511B (da) 1991-11-11
NZ210310A (en) 1988-01-08
SE8406081D0 (sv) 1984-11-30
KR930000046B1 (ko) 1993-01-06
GB2152940A (en) 1985-08-14
FI82601B (fi) 1990-12-31
GB8430083D0 (en) 1985-01-09
AT394948B (de) 1992-07-27
BE901186A (fr) 1985-03-15
FR2555901A1 (fr) 1985-06-07
CA1229551A (en) 1987-11-24
JPS60185728A (ja) 1985-09-21
FI844656A0 (fi) 1984-11-27
IL73594A (en) 1988-12-30
HUT35531A (en) 1985-07-29
IT1177152B (it) 1987-08-26
SE461071B (sv) 1990-01-08
NO167002C (no) 1991-09-25
IT8423523A1 (it) 1986-05-09
GB2152940B (en) 1987-09-03
NL193164C (nl) 1999-01-05
NO167002B (no) 1991-06-17
NL193164B (nl) 1998-09-01
NO844280L (no) 1985-06-03
US4680323A (en) 1987-07-14
IE843077L (en) 1985-06-01
IE58112B1 (en) 1993-07-14
MX161165A (es) 1990-08-09
KR850004392A (ko) 1985-07-15
IT8423523A0 (it) 1984-11-09
DE3443587A1 (de) 1985-06-27
ATA382484A (de) 1992-01-15
PT79427B (en) 1986-09-15
DE3443587C2 (de) 1986-11-06
DK569784D0 (da) 1984-11-30
EG17134A (en) 1991-08-30
DK569784A (da) 1985-06-02
FI82601C (fi) 1991-04-10
IL73594A0 (en) 1985-02-28

Similar Documents

Publication Publication Date Title
DK162511C (da) Baerestof for farmaceutiske praeparater og langtidsvirkende farmaceutiske praeparater indeholdende et saadant baerestof
DK108388A (da) Piperazinylalkylheterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK85985D0 (da) Carbamoyl- eller acyl-4-aza-5alfa-androst-1-en-3-on og farmaceutisk praeparat indeholdende en saadan forbindelse
DK160557C (da) 1,8-naphthyridinforbindelser og farmaceutiske praeparater indeholdende saadanne
DK518984D0 (da) Zinkforbindelser og farmaceutiske praeparater indeholdende disse
DK475684A (da) Phenothiazinderivater og farmaceutiske praeparater indeholdende phenothiazinderivaterne
DK272486D0 (da) Tienopyridoner og farmaceutiske praeparater indeholdende dem
DK163990C (da) Oxindol-3-carboxamid-derivater og farmaceutiske praeparater indeholdende disse
DK375584D0 (da) Piperidinoquinazolinforbindelser og farmaceutisk praeparat indeholdene en saadan forbindelse
DK78888A (da) Arylpiperazinylalkylenphenyl-heterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK537288A (da) Tetrahydrocarbazolester og farmaceutisk praeparat indeholdende en saadan forbindelse
DK272386A (da) Quinoloner og farmaceutiske praeparater indeholdende dem
DK311383D0 (da) Diphosphonsyrederivater og farmaceutiske praeparater indeholdende dem
DK154290C (da) Vitamin-d-derivater og farmaceutiske praeparater indeholdende disse
DK21785A (da) Dihydropyridinforbindelser og farmaceutiske praeparater indeholdende disse
DK81185D0 (da) Carboxicam-enolester-forbindelser og farmaceutiske praeparater indeholdende disse
DK4487A (da) Heterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK52484A (da) Mitomycin-analoger og farmaceutisk praeparat indeholdende en saadan forbindelse
DK422984A (da) Aminocyklopentaner og farmaceutiske praeparater deraf
DK5785A (da) Tricycliske forbindelser, fremgangsmaade til fremstilling heraf og farmaceutisk praeparat indeholdende en saadan forbindelse
DK344384A (da) 2-heterocyclylalkylthio-6-(alfa-hydroxyethyl)-2-penem-3-carboxylsyre-forbindelser og farmaceutiske praeparater indeholdende disse
DK162089C (da) 1-phenoxy-3-hydroxyindolylalkylamino-2-propanoler og farmaceutiske praeparater indeholdende disse
DK488688D0 (da) Azolidindion-derivater og farmaceutiske praeparater indeholdende disse
DK151785D0 (da) 3-aminoalkylthio-1-phenylindolforbindelser og farmaceutiske praeparater
DK547288A (da) 5-substituerede-3-phenyl-3-(1h-imidazol-1-ylmethyl)-2-methylisoxazolidiner og farmaceutiske praeparater indeholdende disse

Legal Events

Date Code Title Description
PUP Patent expired